Norden Group LLC Increases Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Norden Group LLC increased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,139 shares of the company’s stock after buying an additional 235 shares during the quarter. Norden Group LLC’s holdings in U.S. Physical Therapy were worth $456,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Venturi Wealth Management LLC grew its stake in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares during the last quarter. KBC Group NV grew its stake in U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after purchasing an additional 315 shares during the last quarter. Pacer Advisors Inc. purchased a new stake in U.S. Physical Therapy during the 4th quarter valued at about $113,000. First Horizon Advisors Inc. grew its stake in U.S. Physical Therapy by 25.1% during the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock valued at $126,000 after purchasing an additional 298 shares during the last quarter. Finally, International Assets Investment Management LLC grew its stake in U.S. Physical Therapy by 8,414.8% during the 3rd quarter. International Assets Investment Management LLC now owns 2,299 shares of the company’s stock valued at $195,000 after purchasing an additional 2,272 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Barrington Research dropped their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research note on Friday. JPMorgan Chase & Co. boosted their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. StockNews.com cut U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday. JMP Securities began coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Finally, Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $100.00 to $115.00 in a report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and an average price target of $111.50.

Insider Buying and Selling

In related news, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.70% of the stock is currently owned by insiders.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $79.31 on Tuesday. The stock has a market cap of $1.20 billion, a PE ratio of 84.37, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48. The business has a 50-day simple moving average of $88.20 and a 200-day simple moving average of $87.65. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 52-week low of $76.18 and a 52-week high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. On average, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be issued a $0.45 dividend. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a yield of 2.27%. U.S. Physical Therapy’s dividend payout ratio is presently 97.83%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.